tm logo
NUCALA
Live/Registered
REGISTERED AND RENEWED

on 27 Aug 2024

Last Applicant/ Owned by

GSK Medicines Research Centre

Stevenage

GB

SG12NY

Serial Number

85371627 filed on 14th Jul 2011

Registration Number

4714559 registered on 07th Apr 2015

in the Principal Register

Correspondent Address

Christopher M. Hanes

Christopher M. Hanes GLAXOSMITHKLINE

Legal Brand Protection

Durham, NC 27701

United States

Filing Basis

1. intent to use

Disclaimer

NO DATA

NUCALA

[ Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulm Read More

Classification Information


Class [005]
Pharmaceutical Products


[ Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; ] Pharmaceutical preparations and substances for the treatment of [ viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, ] respiratory, [ neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related ] diseases and disorders [ ; Vaccines ]


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 85371627

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 81239707

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
27th Aug 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
27th Aug 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
27th Aug 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
27th Aug 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13th Jun 2024TEAS SECTION 8 & 9 RECEIVED
07th Apr 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05th Jul 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
05th Jul 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05th Jul 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05th Jul 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED